Back
Western Asset High Income Fund II Vs. Novartis AG Industry Stock Comparison
Sell
14
HIX
Western Asset High Income Fund II
Last Price:
$4.29
Seasonality Move:
-4.05%
Buy
71
NVSEF
Novartis AG
Last Price:
$118.70
Seasonality Move:
2.08%
Sell
14
Western Asset High Income Fund II (HIX)
is a Sell
Is Western Asset High Income Fund II a Buy, Sell or Hold?
-
The current Western Asset High Income Fund II [HIX] share price is $4.27. The Score for HIX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
HIX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $118.70. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HIX Stock Price Chart
What is Western Asset High Income Fund II's stock price today?
-
The Western Asset High Income Fund II share price today is $4.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIX is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $118.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
HIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.2 | Buy |
Relative Strength Index (14 RSI): | 48.41 | Sell |
Chaikin Money Flow: | -509567 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.25 - 4.33) | Sell |
Bollinger Bands (100): | (4.06 - 4.32) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 32.51 | Buy |
Relative Strength Index (14 RSI): | 49.99 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (116.5 - 122.38) | Sell |
Bollinger Bands (100): | (107.03 - 118.27) | Buy |
HIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.31 | Sell |
20-day SMA: | 4.3 | Sell |
50-day SMA: | 4.23 | Buy |
200-day SMA: | 4.29 | Sell |
8-day EMA: | 3.86 | Buy |
20-day EMA: | 2.56 | Buy |
50-day EMA: | 1.3 | Buy |
200-day EMA: | 0.37 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 119.98 | Sell |
20-day SMA: | 119.72 | Sell |
50-day SMA: | 115.33 | Buy |
200-day SMA: | 108.26 | Buy |
8-day EMA: | 98.71 | Buy |
20-day EMA: | 60.21 | Buy |
50-day EMA: | 29.23 | Buy |
200-day EMA: | 8.09 | Buy |
Western Asset High Income Fund II Earnings Growth & HIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Western Asset High Income Fund II Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |